Sign in
INBX Stock Price, Chart, Stats & News
Inhibrx Biosciences Inc.
Save
Inhibrx Biosciences Inc. (INBX) is a dividend-paying stock.
INBX chart
Fundamentals
Gross margin | -91.00% |
Operating margin | -10386.54% |
Pretax margin | -10773.31% |
Net margin | -10773.46% |
Effective tax rate | -0.00% |
ROA | -95.62% |
ROE | -269.56% |
D/E | 13.39x |
Interest coverage ratio | -11.07x |
INBX valuation
P/E | – |
P/S | 656.08x |
P/B | 113.13x |
P/CF | -6.97x |
P/FCF | -6.57x |
P/OCF | -6.97x |
PEG | -0.55x |
EV multiple | -6.56x |
About
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P.
Similar securities
Based on sector and market capitalization
Report issue